EUVIMEDEUVIMED entdecken
Crossref

Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome

Waleed Saber Elsayed, Ahmed Saied Abdelrahman, Nabil Ibrahim Fathy

Al-Azhar International Medical Journal · 01.11.2026 · 2026 (11) · 237-241

DOI: 10.21608/aimj.2026.477635.3404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 01.11.2026. Verfasst von Waleed Saber Elsayed und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute respiratory-distress-syndrome (ARDS) is a severe inflammatory lung disease characterized by generalized alveolar injury, impaired oxygenation, and high death rates among critically ill patients. Corticosteroids have been proposed as adjunctive therapy because of their anti-inflammatory effects and potential to accelerate the resolution of pulmonary injury. However, uncertainty persists regarding the comparative effectiveness of different corticosteroid regimens in ARDS.

Aim

To compare the effectiveness and clinical outcomes of methylprednisolone versus hydrocortisone in the treatment of patients with ARDS.

Methods

This prospective study was conducted in the intensive care units of Al-Azhar University Hospitals, Cairo, Egypt. The study included 60 adult patients diagnosed with ARDS according to the Berlin definition. Patients were randomly assigned to two groups. Group M received methyl-prednisolone, while Group H received hydrocortisone. All patients received standard ARDS management. The primary outcome was improvement in gas exchange assessed by the PaO₂/FiO₂ ventilation ratio.

Results

Both treatment groups demonstrated improvement in oxygenation during the study period. Patients treated with methylprednisolone expressed greater improvement in the PaO₂/FiO₂-ratio from day 2 to day 7 compared with the hydrocortisone group. Reductions in inflammatory markers, particularly C-reactive protein and D-dimer, were more pronounced in the methylprednisolone group.

Conclusion

Methylprednisolone may provide greater improvement in oxygenation and inflammatory response compared with hydrocortisone in patients with ARDS.

Zitieren

APA

Elsayed, W. S., Abdelrahman, A. S., & Fathy, N. I. (2026). Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome. Al-Azhar International Medical Journal, 2026(11), 237-241. https://doi.org/10.21608/aimj.2026.477635.3404

Vancouver

Elsayed WS, Abdelrahman AS, Fathy NI. Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome. Al-Azhar International Medical Journal. 2026;2026(11):237-241. doi:10.21608/aimj.2026.477635.3404

BibTeX
@article{Elsayed2026,
  author = {Elsayed, Waleed Saber and Abdelrahman, Ahmed Saied and Fathy, Nabil Ibrahim},
  title = {Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome},
  journal = {Al-Azhar International Medical Journal},
  year = {2026},
  volume = {2026},
  number = {11},
  pages = {237--241},
  doi = {10.21608/aimj.2026.477635.3404}
}
Kostenlos starten →